Welspun Corp — a global pipe leader stepping into a new earnings gear

The Short Version

Welspun Corp is one of the world’s three largest makers of large-diameter steel pipes — the big pipelines that carry oil, gas and water across continents — with factories in India, the US and Saudi Arabia. It has also built a second leg in building materials (water tanks, ductile-iron water pipes, stainless steel, the Sintex brand). The year just ended (FY26) saw record quarterly profits, a record order book of about ₹23,600 crore, and net cash on the balance sheet despite heavy investment. The real story is what’s coming: a cluster of new plants (a US longitudinal-weld mill, Saudi pipe and water-pipe capacity) all commissioning through 2026, which management says will deliver “sizable” extra earnings. Unusually for this batch of in-demand industrials, the stock is moderately valued at ~23 times earnings with healthy ~20%+ returns — arguably the cleanest risk/reward setup of the lot, with the usual caveat that this is a cyclical, project-driven business.

What This Company Actually Does

When a country builds an oil or gas pipeline, or a major water-transmission line, it needs huge, precisely-welded steel pipes that can run for decades under pressure. Welspun Corp is a top-3 global maker of these “line pipes,” with the rare advantage of being a local producer in three key markets — India, the US (via Welspun Tubular) and Saudi Arabia — which matters enormously because it sidesteps the import tariffs and anti-dumping duties that hobble exporters. (Asked about US tariffs, management’s answer was blunt: the impact is “zero,” because it makes pipe inside the US.)

Around this core, Welspun has built a building-materials and new-products arm: ductile-iron (DI) pipes for water networks, steel billets and TMT rebars, stainless-steel pipes and bars (WSSL — aimed at nuclear, defence, data centres), and the Sintex brand (India’s leading water-tank maker, now expanding into plastic pipes). The model is essentially order-book-driven heavy engineering (lumpy, project-cyclical large pipe contracts) layered with a steadier consumer/building-products portfolio.

The Welspun group (Goenka family) owns ~50%. The financials are healthy and — importantly — the valuation is reasonable: ROCE ~23%, ROE ~19%, a P/E of ~23, and a net-cash balance sheet even after ~₹1,700 crore of capex in nine months. Raw-material cost (steel, coking coal) is largely a contractual pass-through, so margins are insulated from commodity swings. One thing to read carefully: reported profit has had one-off distortions (a large gain from selling EPIC shares in the prior year), so the underlying earnings trend is smoother and more upward than the headline jumps suggest.

The Long Game

Welspun’s long game is a genuine earnings step-up as new capacity comes online, backed by a record order book and structural demand in all three geographies:

United States — its US spiral-pipe mill is booked solid through March 2028, and management is adding a new longitudinal-weld (LSAW) mill (live by end-2026, making Welspun one of only two US LSAW players) plus upgrading another mill for larger pipe. Demand drivers: 8–9 pipelines under discussion, plus carbon-capture, hydrogen and offshore.
Saudi Arabia — Aramco raised its capex plan to $50–55 billion (the Jafurah gas project, ~4,000 km of new pipelines), and Welspun is adding pipe and ductile-iron capacity there; a Saudi anti-dumping probe on cheap imports could open ~two-thirds of the local DI market to it.
India — domestic oil & gas pipelines reviving (GAIL, the LNG and city-gas build-out), and water (the JJM scheme, with ₹70,000 crore freshly announced) recovering after a slow patch; DI-pipe volumes grew ~39%.
Building materials — Sintex regaining water-tank share and launching OPVC pipes; stainless steel positioned for nuclear/data-centre/defence demand.

Management’s framing: all 7–8 announced projects deliver between mid and late 2026, after which “the incremental earnings are going to be sizable,” with new projects cleared only at a ~20% return-on-capital threshold. It positions itself as a “Tier-1 player” that cherry-picks the top, higher-margin end of the market rather than chasing volume. The reason to believe it: the order book is real and at a record, the balance sheet is net-cash, returns are already healthy, and the valuation isn’t demanding. The reason for discipline: this is cyclical, project-driven heavy engineering — quarters are lumpy, India’s water/oil capex has stop-start funding, and the earnings step-up depends on executing several big projects at once.

The Story So Far

The thread through FY26: margins climbed quarter after quarter to record levels, the order book hit records, and management built toward a 2026 capacity step-up — while staying net-cash through heavy capex.

Q1–Q2 FY26 (reported July & November) — margins inflect up

Operating margins stepped up to 14–15% (from the 7–12% range a year earlier) on a richer project mix and the Tier-1 cherry-picking strategy. The US mill stayed booked out, Saudi expansion advanced, and the building-materials arm (DI pipes, Sintex) grew. Management reaffirmed full-year EBITDA guidance of ~₹2,200 crore.

Q3 FY26 (reported February) — record profit, record book

The highest-ever quarterly EBITDA (₹645 crore, eight straight quarters of growth), with nine-month EBITDA at ₹1,831 crore already near the full-year ₹2,200 crore guidance — so management said it would “comfortably achieve or exceed” it. The consolidated order book hit a record ~₹23,600 crore. DI-pipe volumes were up ~39%; the US spiral mill ran at 85–90% utilisation, booked through 2028.

“As our projects get completed over the next 2 or 3 quarters at best, the incremental earnings are going to be sizable.” — Vipul Mathur, MD & CEO (Q3)

Q4 / full-year FY26 (reported May) — a strong year, building to more

The full year closed with record results (revenue ~₹16,800 crore, sharply higher margins), net cash maintained despite the heavy capex, and the seven-to-eight new projects (US LSAW, Saudi DI and LSAW, Indian lines) on track to deliver through calendar 2026. Management deferred FY27 guidance to be given formally on this call cycle but pointed clearly to the capacity-driven earnings step-up ahead.

The pattern a long-term investor should read: this is a well-run, globally-diversified market leader executing a capacity expansion into genuine demand, with the order book and net-cash balance sheet to back it — and, refreshingly, at a price that doesn’t already assume perfection. The honest caveats are the nature of the business (cyclical, project-lumpy, dependent on global oil & gas and Indian water-scheme capex cycles) and the execution risk of commissioning several large plants simultaneously through 2026.

Where Things Stand

Welspun enters FY27 with a record ₹23,600 crore order book, a US mill booked through 2028, a cluster of new plants (US LSAW, Saudi DI/LSAW) commissioning through 2026 that should lift earnings meaningfully, healthy ~20%+ returns, a net-cash balance sheet, tariff-insulated local production in its key markets, and raw-material pass-throughs protecting margins. The demand backdrop — US pipelines (including carbon-capture and hydrogen), Saudi Aramco’s $50-billion-plus capex, India’s reviving water and gas networks — is structural and multi-year.

The honest counterweights are inherent to the model rather than signs of trouble: it’s a cyclical, project-driven business, so quarters are lumpy and the order book ebbs and flows with global oil & gas and Indian water-scheme funding cycles (Indian water demand was slow for parts of the year before reviving); reported profit has carried one-off distortions worth reading past; and the coming earnings step-up depends on delivering several big projects at once through 2026. For a patient investor, what stands out is the combination this batch mostly lacked: a genuine order-book-backed growth story and a moderate valuation (~23× earnings) with strong returns and net cash — a more balanced risk/reward than the richly-priced names, provided the project execution lands and the cycle cooperates.

The Four Checks

1. Quality and moat. A well-run business with a real but cycle-bound edge, not a fortress. The advantages are concrete: top-3 global position in large-diameter line pipes, local plants in all three key markets (so US tariffs cost it “zero” while hobbling importers), qualification with the top two or three US midstream buyers, a 22-year Saudi presence, and — once the new mill is live — one of only two LSAW producers in the US. These are genuine barriers: a rival cannot conjure an accredited US or Saudi plant overnight. But the product is still project-driven heavy engineering sold into capex cycles, and the company’s own history shows what that means — a net loss in FY19, operating margins at 5% in FY23, then 13–14% at the current peak. The moat protects its share of the cycle; it does not protect it from the cycle.

2. Returns on incremental capital and runway. Strongly improving, with the honest caveat that the reading is taken at high tide. ROCE climbed from 6% in FY23 to ~23% by FY26 (the June 2026 snapshot shows 22.9%, ROE 19.4%), and management clears new projects only at a ~20% return-on-capital threshold. The reinvestment is heavy and visible — CWIP up from ₹87 crore (FY24) to ₹1,233 crore (FY26), fixed assets up ₹1,800 crore — and the runway is unusually well-evidenced for a cyclical: an order book above ₹25,000 crore, plants booked through FY28, and management framing the US gas build-out as a five-to-seven-year structural play. Negative working capital (customers paying advances to book capacity) is doing part of the ROCE work. The engine currently redeploys at attractive rates into real demand; what the data cannot tell you is what those incremental returns look like when the cycle turns, and the FY23 trough says they compress hard.

3. Capital allocation for the stage. Largely textbook for a build phase. Management is reinvesting hard while returns are high — roughly ₹3,700 crore of investing outflow in FY26 against ₹3,204 crore of operating cash flow — while keeping the balance sheet net cash and cutting gross debt to modest levels (₹2,355 crore against ₹9,000+ crore of reserves). Dividends are deliberately token (7–8% payout, ~0.35% yield), which is the right call when projects earn 20%+. No buyback history is visible in the data, and no meaningful dilution either; the Sintex acquisition (FY24) added a steadier consumer leg rather than an empire. The quibbles: a negligible promoter trim (50% to 49.73%), an MD increment payable “irrespective of whether the Company has adequate profits,” group-restructuring moves (the EPIC stake shuffled between Welspun entities) that take some trust, and a stated cash-deployment plan that is still a promise — management says it will address surplus cash “a few quarters away,” once the plants are commissioned. Rational so far; the test comes when the cash piles up.

4. Price. Full but defensible — for a cyclical. As of the June 2026 snapshot, the stock trades at ₹1,370, a P/E of 22.5 on a ₹36,223 crore market cap, having nearly doubled off its 52-week low of ₹710 and sitting near the ₹1,428 high. That multiple sits on record earnings: FY26 operating profit of ₹2,236 crore at a 13% margin that is the best in the company’s history, against a past that includes 5–7% margins and a loss year. What you get for paying it: an order book booked through FY28, guided FY27 EBITDA of ₹2,850 crore (about 20% growth, putting the forward multiple in the high teens), net cash, and 23% ROCE. Among capacity-expansion stories this remains one of the more moderately priced — but a buyer at 22.5 times peak-cycle earnings is underwriting both the project execution and the cycle holding through 2028. Fair for the visibility on offer; not cheap.

Sources

Concall transcripts (4): Q1 FY26 (Jul 30, 2025), Q2 FY26 (Oct 31, 2025), Q3 FY26 (Feb 2, 2026), Q4 FY26 + full-year (May 22, 2026) — BSE filings, converted to markdown. These carried the order-book, project-pipeline, guidance and segment detail.
Annual reports (3): FY23, FY24, FY25 sections — extracts were thin on segment-level profit and order-book detail (flagged in the digests); the financial arc leans on the screener tables and concalls.
Screener.in snapshot: quarterly and annual tables, ratios, shareholding — fetched 2026-06-07 (logged-out session).
Research files: vault/Sources/Earnings/Welspun Corp Ltd/ — raw transcripts, AR sections, snapshot, per-document digests (not published).